Gå direkt till innehåll

Kategorier: european patent

  • Cereno Scientific obtains patents in 15 European countries solidifying CS1’s protection

    Cereno Scientific obtains patents in 15 European countries solidifying CS1’s protection

    Cereno Scientific (XSAT: CRNO B) today announced that CS1’s first patent family has been granted patents in 15 European countries following a completed validation and opposition period. This adds to the already granted markets that include Australia, Canada, Japan, and the US, thus securing patent protection for CS1 in nearly all global key markets.

  • Sobrera Pharma receives patent approval in Europe

    Sobrera Pharma receives patent approval in Europe

    Sobrera Pharma AB is pleased to announce the Decisions to Grant on the European patent 3582764 titled ’Treatment of Alcohol Use’ by the European Patent Office (EPO). The decision to grant on the patent provides a protection of our drug candidate SO-001 for use in treating alcohol use disorder (AUD) and/or treating alcohol risk consumption.